BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30508692)

  • 1. Exploring PfDHFR reaction surface: A combined molecular dynamics and QM/MM analysis.
    Abbat S; Jaladanki CK; Bharatam PV
    J Mol Graph Model; 2019 Mar; 87():76-88. PubMed ID: 30508692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origins of the specificity of inhibitor P218 toward wild-type and mutant PfDHFR: a molecular dynamics analysis.
    Abbat S; Jain V; Bharatam PV
    J Biomol Struct Dyn; 2015 Sep; 33(9):1913-28. PubMed ID: 25333695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energetically most likely substrate and active-site protonation sites and pathways in the catalytic mechanism of dihydrofolate reductase.
    Cummins PL; Gready JE
    J Am Chem Soc; 2001 Apr; 123(15):3418-28. PubMed ID: 11472112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes in the active site loops of dihydrofolate reductase during the catalytic cycle.
    Venkitakrishnan RP; Zaborowski E; McElheny D; Benkovic SJ; Dyson HJ; Wright PE
    Biochemistry; 2004 Dec; 43(51):16046-55. PubMed ID: 15609999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of
    Manhas A; Lone MY; Jha PC
    J Biomol Struct Dyn; 2019 Oct; 37(16):4181-4199. PubMed ID: 30648473
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum.
    Mokmak W; Chunsrivirot S; Hannongbua S; Yuthavong Y; Tongsima S; Kamchonwongpaisan S
    Chem Biol Drug Des; 2014 Oct; 84(4):450-61. PubMed ID: 24716467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of water in the catalytic cycle of E. coli dihydrofolate reductase.
    Shrimpton P; Allemann RK
    Protein Sci; 2002 Jun; 11(6):1442-51. PubMed ID: 12021443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glutamine 67--> histidine mutation in homotetrameric R67 dihydrofolate reductase results in four mutations per single active site pore and causes substantial substrate and cofactor inhibition.
    Park H; Bradrick TD; Howell EE
    Protein Eng; 1997 Dec; 10(12):1415-24. PubMed ID: 9543003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction-path energetics and kinetics of the hydride transfer reaction catalyzed by dihydrofolate reductase.
    Garcia-Viloca M; Truhlar DG; Gao J
    Biochemistry; 2003 Nov; 42(46):13558-75. PubMed ID: 14622003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the Met
    Mhashal AR; Vardi-Kilshtain A; Kohen A; Major DT
    J Biol Chem; 2017 Aug; 292(34):14229-14239. PubMed ID: 28620051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cofactor-Mediated Conformational Dynamics Promote Product Release From Escherichia coli Dihydrofolate Reductase via an Allosteric Pathway.
    Oyen D; Fenwick RB; Stanfield RL; Dyson HJ; Wright PE
    J Am Chem Soc; 2015 Jul; 137(29):9459-68. PubMed ID: 26147643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key interactions of pyrimethamine derivatives specific to wild-type and mutant
    Seetin S; Saparpakorn P; Vanichtanankul J; Vitsupakorn D; Yuthavong Y; Kamchonwongpaisan S; Hannongbua S
    J Biomol Struct Dyn; 2023; 41(12):5728-5743. PubMed ID: 35815526
    [No Abstract]   [Full Text] [Related]  

  • 13. Tales of Dihydrofolate Binding to R67 Dihydrofolate Reductase.
    Duff MR; Chopra S; Strader MB; Agarwal PK; Howell EE
    Biochemistry; 2016 Jan; 55(1):133-45. PubMed ID: 26637016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QM/MM and SCRF studies of the ionization state of 8-methylpterin substrate bound to dihydrofolate reductase: existence of a low-barrier hydrogen bond.
    Cummins PL; Gready JE
    J Mol Graph Model; 2000 Feb; 18(1):42-9. PubMed ID: 10935206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward resolving the catalytic mechanism of dihydrofolate reductase using neutron and ultrahigh-resolution X-ray crystallography.
    Wan Q; Bennett BC; Wilson MA; Kovalevsky A; Langan P; Howell EE; Dealwis C
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18225-30. PubMed ID: 25453083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breaking symmetry: mutations engineered into R67 dihydrofolate reductase, a D2 symmetric homotetramer possessing a single active site pore.
    Smiley RD; Stinnett LG; Saxton AM; Howell EE
    Biochemistry; 2002 Dec; 41(52):15664-75. PubMed ID: 12501195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free energy simulations of active-site mutants of dihydrofolate reductase.
    Doron D; Stojković V; Gakhar L; Vardi-Kilshtain A; Kohen A; Major DT
    J Phys Chem B; 2015 Jan; 119(3):906-16. PubMed ID: 25382260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a type II dihydrofolate reductase catalytic ternary complex.
    Krahn JM; Jackson MR; DeRose EF; Howell EE; London RE
    Biochemistry; 2007 Dec; 46(51):14878-88. PubMed ID: 18052202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the electrostatics of active site microenvironments along the catalytic cycle for Escherichia coli dihydrofolate reductase.
    Liu CT; Layfield JP; Stewart RJ; French JB; Hanoian P; Asbury JB; Hammes-Schiffer S; Benkovic SJ
    J Am Chem Soc; 2014 Jul; 136(29):10349-60. PubMed ID: 24977791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are homology models sufficiently good for free-energy simulations?
    Genheden S
    J Chem Inf Model; 2012 Nov; 52(11):3013-21. PubMed ID: 23113602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.